化疗所致恶心呕吐的药物防治指南

2022-01-05 中国药学会医院药学专业委员会 中国医院药学杂志

近年来!分子靶向药物、免疫治疗药物等各类抗肿瘤药物层出不穷。但是,化疗仍然是当前抗肿瘤药物治疗中不可或缺的治疗方式。然而,化疗所致的恶心呕吐是肿瘤患者化疗过程中最常见且最令人畏惧的不良反应。据统计,如

中文标题:

化疗所致恶心呕吐的药物防治指南

发布日期:

2022-01-05

简要介绍:

近年来!分子靶向药物、免疫治疗药物等各类抗肿瘤药物层出不穷。但是,化疗仍然是当前抗肿瘤药物治疗中不可或缺的治疗方式。然而,化疗所致的恶心呕吐是肿瘤患者化疗过程中最常见且最令人畏惧的不良反应。据统计,如果在化疗过程中不给予预防呕吐用药70%-80%的患者会出现恶心呕吐,可导致脱水、代谢紊乱、自理能力下降、营养缺乏、厌食、体力下降、伤口裂开及食管黏膜撕裂等不良后果。CINV显著影响患者的生活质量,进而降低患者后续抗肿瘤治疗的依从性,甚至导致患者终止治疗。

相关资料下载:
[AttachmentFileName(sort=1, fileName=化疗所致恶心呕吐的药物防治指南.pdf)] GetToolGuiderByIdResponse(projectId=1, id=7fdf61c00239289f, title=化疗所致恶心呕吐的药物防治指南, enTitle=, guiderFrom=中国医院药学杂志, authorId=0, author=, summary=近年来!分子靶向药物、免疫治疗药物等各类抗肿瘤药物层出不穷。但是,化疗仍然是当前抗肿瘤药物治疗中不可或缺的治疗方式。然而,化疗所致的恶心呕吐是肿瘤患者化疗过程中最常见且最令人畏惧的不良反应。据统计,如, cover=https://img.medsci.cn/2022324/1648090766037_5579292.png, journalId=0, articlesId=null, associationId=2119, associationName=中国药学会医院药学专业委员会, associationIntro=中国药学会医院药学专业委员会, copyright=0, guiderPublishedTime=Wed Jan 05 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p>近年来!分子靶向药物、免疫治疗药物等各类抗肿瘤药物层出不穷。但是,化疗仍然是当前抗肿瘤药物治疗中不可或缺的治疗方式。然而,化疗所致的恶心呕吐是肿瘤患者化疗过程中最常见且最令人畏惧的不良反应。据统计,如果在化疗过程中不给予预防呕吐用药70%-80%的患者会出现恶心呕吐,可导致脱水、代谢紊乱、自理能力下降、营养缺乏、厌食、体力下降、伤口裂开及食管黏膜撕裂等不良后果。CINV显著影响患者的生活质量,进而降低患者后续抗肿瘤治疗的依从性,甚至导致患者终止治疗。</p>, tagList=[TagDto(tagId=282, tagName=化疗), TagDto(tagId=22294, tagName=止吐药物)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3058, appHits=326, showAppHits=0, pcHits=641, showPcHits=2732, likes=2, shares=55, comments=6, approvalStatus=1, publishedTime=Thu Mar 24 15:33:00 CST 2022, publishedTimeString=2022-01-05, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Thu Mar 24 11:01:05 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 16:24:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=化疗所致恶心呕吐的药物防治指南.pdf)])
化疗所致恶心呕吐的药物防治指南.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1218133, encodeId=d49e1218133c7, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33544, encryptionId=adf23354483, topicName=化疗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 12:56:25 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210089, encodeId=5f8e12100892c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66e8108716, createdName=ms5000000188518580, createdTime=Sun Apr 10 18:44:49 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207234, encodeId=24b5120e23468, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220327/913929b6ce7147e496d89ca08cd7c08b/81a57acbbb7441678988eed89418858b.jpg, createdBy=44de6532916, createdName=IIceylu, createdTime=Wed Mar 30 15:50:52 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205647, encodeId=635f120564e16, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51e25436463, createdName=ms5000001884318066, createdTime=Thu Mar 24 19:05:58 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205778, encodeId=30e51205e7885, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8572809219, createdName=liudf21, createdTime=Fri Mar 25 09:20:56 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1218133, encodeId=d49e1218133c7, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33544, encryptionId=adf23354483, topicName=化疗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 12:56:25 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210089, encodeId=5f8e12100892c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66e8108716, createdName=ms5000000188518580, createdTime=Sun Apr 10 18:44:49 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207234, encodeId=24b5120e23468, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220327/913929b6ce7147e496d89ca08cd7c08b/81a57acbbb7441678988eed89418858b.jpg, createdBy=44de6532916, createdName=IIceylu, createdTime=Wed Mar 30 15:50:52 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205647, encodeId=635f120564e16, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51e25436463, createdName=ms5000001884318066, createdTime=Thu Mar 24 19:05:58 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205778, encodeId=30e51205e7885, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8572809219, createdName=liudf21, createdTime=Fri Mar 25 09:20:56 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
    2022-04-10 ms5000000188518580

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1218133, encodeId=d49e1218133c7, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33544, encryptionId=adf23354483, topicName=化疗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 12:56:25 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210089, encodeId=5f8e12100892c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66e8108716, createdName=ms5000000188518580, createdTime=Sun Apr 10 18:44:49 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207234, encodeId=24b5120e23468, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220327/913929b6ce7147e496d89ca08cd7c08b/81a57acbbb7441678988eed89418858b.jpg, createdBy=44de6532916, createdName=IIceylu, createdTime=Wed Mar 30 15:50:52 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205647, encodeId=635f120564e16, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51e25436463, createdName=ms5000001884318066, createdTime=Thu Mar 24 19:05:58 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205778, encodeId=30e51205e7885, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8572809219, createdName=liudf21, createdTime=Fri Mar 25 09:20:56 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
    2022-03-30 IIceylu

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1218133, encodeId=d49e1218133c7, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33544, encryptionId=adf23354483, topicName=化疗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 12:56:25 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210089, encodeId=5f8e12100892c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66e8108716, createdName=ms5000000188518580, createdTime=Sun Apr 10 18:44:49 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207234, encodeId=24b5120e23468, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220327/913929b6ce7147e496d89ca08cd7c08b/81a57acbbb7441678988eed89418858b.jpg, createdBy=44de6532916, createdName=IIceylu, createdTime=Wed Mar 30 15:50:52 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205647, encodeId=635f120564e16, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51e25436463, createdName=ms5000001884318066, createdTime=Thu Mar 24 19:05:58 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205778, encodeId=30e51205e7885, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8572809219, createdName=liudf21, createdTime=Fri Mar 25 09:20:56 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
    2022-03-24 ms5000001884318066

    很好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1218133, encodeId=d49e1218133c7, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33544, encryptionId=adf23354483, topicName=化疗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 12:56:25 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210089, encodeId=5f8e12100892c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66e8108716, createdName=ms5000000188518580, createdTime=Sun Apr 10 18:44:49 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207234, encodeId=24b5120e23468, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220327/913929b6ce7147e496d89ca08cd7c08b/81a57acbbb7441678988eed89418858b.jpg, createdBy=44de6532916, createdName=IIceylu, createdTime=Wed Mar 30 15:50:52 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205647, encodeId=635f120564e16, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51e25436463, createdName=ms5000001884318066, createdTime=Thu Mar 24 19:05:58 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205778, encodeId=30e51205e7885, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8572809219, createdName=liudf21, createdTime=Fri Mar 25 09:20:56 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
    2022-03-25 liudf21

    很实用

    0